# Oleuropein (Olea europaea)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/oleuropein-olea-europaea
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-04
**Evidence Score:** 1 / 10
**Category:** Compound
**Also Known As:** Olea europaea leaf phenol, secoiridoid glucoside, OLE active compound, 2-(3,4-dihydroxyphenyl)ethyl ester of oleuropeic acid, olive polyphenol

## Overview

Oleuropein is a secoiridoid glucoside that exerts [antioxidant activity](/ingredients/condition/antioxidant) through free-radical scavenging (DPPH: 322.54 μmol TE/100 g) and hydrolyzes in vivo to hydroxytyrosol, amplifying its phenolic bioactivity. Preclinical evidence demonstrates cardioprotective, [antimicrobial](/ingredients/condition/immune-support), and [anti-inflammatory](/ingredients/condition/inflammation) potential, but large-scale randomized controlled trials in humans remain limited, restricting definitive clinical claims.

## Health Benefits

- **Antioxidant Activity**: Oleuropein's polyphenolic catechol structure scavenges [reactive oxygen species](/ingredients/condition/antioxidant) with a measured DPPH radical inhibition of 322.54 μmol TE/100 g and FRAP of 7.2 μmol TE/100 mL; hydrolysis to hydroxytyrosol further amplifies electron-donating capacity.
- **Cardioprotective Potential**: Preclinical models show oleuropein may reduce LDL oxidation, lower [blood pressure](/ingredients/condition/heart-health) via ACE inhibition, and attenuate endothelial inflammation, forming the basis of its classification as a cardioprotective compound.
- **[Antimicrobial](/ingredients/condition/immune-support) Action**: Olive leaf extract (OLE) containing oleuropein demonstrates inhibition of Candida albicans (zone of inhibition: 7.7 ± 0.14 mm) and bacterial pathogens, with minimum inhibitory concentrations of 4–24 mg/mL attributed to phenolic disruption of microbial membranes.
- **Anti-Inflammatory Properties**: Oleuropein modulates NF-κB signaling and suppresses [pro-inflammatory cytokine](/ingredients/condition/inflammation) production (TNF-α, IL-6) in cell-based models, suggesting systemic anti-inflammatory potential relevant to metabolic and cardiovascular disease.
- **Glycemic Regulation**: Animal studies indicate oleuropein may improve insulin secretion and sensitivity by protecting pancreatic beta cells from oxidative stress and stimulating glucose uptake in skeletal muscle tissue.
- **[Neuroprotective Effect](/ingredients/condition/cognitive)s**: In vitro and rodent studies suggest oleuropein and its aglycone inhibit amyloid-beta aggregation and reduce neuroinflammatory markers, positioning it as a candidate compound for neurodegenerative disease research.
- **Antimicrobial Spectrum Broadening via Metabolite Production**: Upon hydrolysis by gut microbiota or [digestive enzyme](/ingredients/condition/gut-health)s, oleuropein yields hydroxytyrosol and elenolic acid, both of which possess independent antimicrobial and antioxidant activity, extending the compound's functional reach beyond the parent molecule.

## Mechanism of Action

Oleuropein's primary antioxidant mechanism stems from its ortho-diphenolic catechol moiety, which donates hydrogen atoms to neutralize [free radical](/ingredients/condition/antioxidant)s and chelates pro-oxidant transition metals such as iron and copper, preventing Fenton-type reactions. Upon enzymatic or acidic hydrolysis, oleuropein yields hydroxytyrosol (a potent antioxidant) and elenolic acid, with NMR confirmation of characteristic RCH₂O carbon shifts at δC 73.29 and 60.73 ppm supporting the glucoside structure's reactivity profile. At the cellular level, oleuropein activates Nrf2/ARE pathways to upregulate endogenous antioxidant enzymes (superoxide dismutase, catalase, [glutathione](/ingredients/condition/detox) peroxidase) and suppresses NF-κB-mediated transcription of pro-[inflammatory](/ingredients/condition/inflammation) mediators including COX-2, TNF-α, and IL-1β. Its [antimicrobial](/ingredients/condition/immune-support) effect is attributed to phenolic disruption of lipid bilayer integrity in microbial membranes, impairing membrane potential and intracellular enzyme function without the cytotoxic profile observed with conventional antibiotics at tested MIC ranges.

## Clinical Summary

No large-scale randomized controlled trials specifically isolating oleuropein as a pure compound in human subjects have been published to date; most human research involves standardized olive leaf extracts (OLE) containing oleuropein as the primary but not sole bioactive. Small pilot studies with OLE in hypertensive adults have reported modest systolic [blood pressure](/ingredients/condition/heart-health) reductions (approximately 11–13 mmHg in some reports), though these findings require replication with rigorous controls. Glycemic outcomes in pre-diabetic and type 2 diabetic populations have been explored in limited trials, with inconsistent results reflecting variable extract standardization and dose heterogeneity. Overall confidence in oleuropein-specific clinical outcomes is low, and the compound's cardioprotective classification rests primarily on mechanistic plausibility derived from preclinical data rather than demonstrated human efficacy.

## Nutritional Profile

Oleuropein is a pure phenolic secoiridoid glucoside (molecular formula C₂₅H₃₂O₁₃; MW ~540 g/mol) rather than a macronutrient-containing food matrix, and therefore contributes negligible calories, protein, fat, or carbohydrate when consumed in supplement doses. In the context of whole olive leaf, total phenolic content (TPC) of non-encapsulated OLE reaches 395.45 mg EAG/g, with oleuropein as the dominant fraction. Co-occurring phenolics include hydroxytyrosol glucoside (1.56–7.38 mg/kg EDW), hydroxytyrosol acetate, luteolin-7-O-glucoside, apigenin-7-O-glucoside, quinic acid, cycloolivil, and olivil, each contributing independently to overall [antioxidant](/ingredients/condition/antioxidant) capacity. Bioavailability of oleuropein is influenced by gut microbiota hydrolysis to hydroxytyrosol and elenolic acid, food matrix effects, and encapsulation technology; plasma pharmacokinetic data in humans are not yet well characterized in the published literature.

## Dosage & Preparation

- **Olive Leaf Extract (OLE) Capsules/Tablets**: Most commercially available supplements are standardized to 6–25% oleuropein content; commonly studied doses of OLE range from 500–1000 mg/day in adult populations.
- **Freeze-Dried Leaf Powder**: Freeze-drying preserves the highest oleuropein content (up to 111.82 mg/kg DW in 'Arbequina' cultivar); used in encapsulated or powdered supplement forms.
- **Aqueous or Hydroethanolic Extract**: Prepared via autoclave or maceration extraction; optimal yields achieved at ~1500 ppm OLE with high-speed homogenization (10,000 rpm for 30 seconds).
- **Encapsulated OLE**: Maltodextrin/sodium caseinate encapsulation improves stability and bioavailability by protecting oleuropein from oxidative degradation during storage and gastrointestinal transit.
- **Traditional Olive Leaf Tea**: Dried leaves steeped in hot water; phenolic content is lower than standardized extracts due to thermal degradation and incomplete extraction efficiency.
- **Standardization Note**: Harvesting outside hot summer months and using freeze-drying or air-drying (rather than oven-drying above 60°C) maximizes oleuropein retention; oven-drying 'Menara' at 60°C reduced oleuropein to as low as 15.24 mg/kg DW.
- **Timing**: No pharmacokinetic data in humans establishes optimal dosing timing; divided daily doses with meals are commonly recommended to minimize potential gastrointestinal discomfort.

## Safety & Drug Interactions

Oleuropein and olive leaf extracts are generally regarded as well-tolerated at doses used in preclinical and small pilot studies, with no serious adverse events reported in the available literature; mild gastrointestinal discomfort (nausea, loose stools) has been anecdotally noted at higher OLE doses. Given its demonstrated ACE-inhibitory and vasodilatory properties in animal models, oleuropein may theoretically potentiate the effects of antihypertensive medications (ACE inhibitors, ARBs, calcium channel blockers), warranting clinical monitoring in patients on these drug classes. Potential additive hypoglycemic effects with insulin or oral antidiabetic agents (metformin, sulfonylureas) are biologically plausible based on preclinical glycemic data, but have not been formally evaluated in human drug-interaction studies. No established maximum safe dose has been defined for pure oleuropein in humans; pregnant and lactating individuals should exercise caution and consult a healthcare provider given the absence of dedicated safety data in these populations.

## Scientific Research

The evidence base for oleuropein consists predominantly of in vitro assays and animal model studies, with robust human clinical trial data absent from the current peer-reviewed literature. [Antioxidant](/ingredients/condition/antioxidant) quantification has been rigorously conducted via standardized DPPH and FRAP assays, and [antimicrobial](/ingredients/condition/immune-support) efficacy against Candida albicans and bacterial strains has been replicated across multiple laboratory studies using OLE preparations. Some small human observational and pilot intervention trials exist for olive leaf extract broadly (not pure oleuropein), suggesting modest [blood pressure](/ingredients/condition/heart-health) and glycemic benefits, but these lack the sample sizes, blinding, and effect-size reporting required for high-confidence clinical conclusions. The compound's evidence profile is best characterized as preclinical-to-emerging-clinical, warranting further investigation through appropriately powered randomized controlled trials with standardized oleuropein doses.

## Historical & Cultural Context

The olive tree (Olea europaea) holds one of the longest documented histories in Mediterranean civilization, with cultivation records extending approximately 6,000–7,000 years and references in ancient Greek, Egyptian, and Hebrew texts describing medicinal use of leaves for fever, infection, and wound healing. Traditional Mediterranean healers prepared olive leaf decoctions to treat malaria-like fevers, a practice later attributed in part to oleuropein's [antimicrobial](/ingredients/condition/immune-support) and antipyretic properties. In Greco-Roman medicine, olive leaves were applied topically for skin infections and consumed as teas for systemic ailments, with the plant's cultural significance extending to religious symbolism in Christianity, Judaism, and Islam. Modern phytochemical valorization of olive pruning waste—yielding 1–11 tonnes of leaf biomass per hectare annually—represents a contemporary intersection of traditional knowledge and evidence-based ingredient science.

## Synergistic Combinations

Oleuropein exhibits documented synergy with hydroxytyrosol—its primary hydrolytic metabolite—as co-administration or sequential metabolic conversion amplifies total [antioxidant](/ingredients/condition/antioxidant) capacity beyond either compound alone, an effect attributed to complementary radical-scavenging mechanisms and differing lipophilicity enabling broader tissue distribution. Combination with vitamin C (ascorbic acid) and vitamin E (tocopherols) has been proposed to regenerate oxidized oleuropein-derived phenols and extend antioxidant cycling via aqueous and lipid compartments respectively, a common strategy in Mediterranean diet-aligned antioxidant formulations. Pairing OLE with quercetin or resveratrol may provide additive [NF-κB](/ingredients/condition/inflammation) suppression and Nrf2 activation, though synergistic human data for these specific stack combinations remain preliminary.

## Frequently Asked Questions

### What is oleuropein and what does it do in the body?

Oleuropein is a secoiridoid glucoside and the most abundant phenolic compound in olive (Olea europaea) leaves, comprising up to 111.82 mg/kg DW in freeze-dried cultivars. In the body, it acts as a direct free-radical scavenger via its catechol moiety and is hydrolyzed by gut enzymes and microbiota into hydroxytyrosol and elenolic acid, both of which retain independent antioxidant and antimicrobial activity. It also activates Nrf2 signaling to upregulate endogenous antioxidant enzymes and suppresses NF-κB-driven inflammation at the cellular level.

### What is the recommended dosage of oleuropein or olive leaf extract?

No universally established clinical dosage for pure oleuropein exists due to limited large-scale human trials; most commercial olive leaf extract (OLE) supplements are standardized to 6–25% oleuropein content and used at total OLE doses of 500–1000 mg/day in adult research contexts. Effective oleuropein delivery depends heavily on extraction method and standardization—freeze-dried preparations preserve the highest oleuropein concentrations. Divided doses taken with meals are commonly recommended to support tolerability, though formal pharmacokinetic guidance in humans is lacking.

### Is oleuropein safe, and does it interact with any medications?

Oleuropein and OLE are considered generally safe at supplemental doses based on available preclinical and limited human data, with no serious adverse events formally documented. However, due to its potential ACE-inhibitory and vasodilatory effects demonstrated in animal models, it may enhance the blood-pressure-lowering action of antihypertensive drugs such as ACE inhibitors, ARBs, and calcium channel blockers—requiring medical supervision. Additive hypoglycemic effects with antidiabetic medications are also biologically plausible, and pregnant or breastfeeding individuals should consult a healthcare provider before use.

### How does oleuropein compare to hydroxytyrosol?

Oleuropein is the parent secoiridoid glucoside and the most concentrated phenol in olive leaves (up to ~112 mg/kg DW freeze-dried), while hydroxytyrosol is a minor direct constituent (1.56–7.38 mg/kg EDW as glucoside) but is the primary bioactive metabolite formed when oleuropein is hydrolyzed. Hydroxytyrosol is generally considered more bioavailable and lipophilic than the parent glucoside, allowing it to penetrate cell membranes more effectively, whereas oleuropein provides sustained release of this metabolite and exerts additional direct effects including elenolic acid production. Both compounds contribute synergistically to the overall antioxidant and anti-inflammatory profile of olive-derived supplements.

### What is the difference between oleuropein from olive leaves versus olive oil?

Olive leaves are by far the richest source of oleuropein, with concentrations ranging from 15–112 mg/kg DW depending on cultivar and drying method, making them the preferred raw material for standardized OLE supplements. Extra virgin olive oil contains significantly lower and more variable oleuropein levels, as much of the compound is lost during the mechanical pressing process, remaining instead in the olive vegetation water (amurca) and pomace. Olive oil is comparatively richer in oleocanthal and oleacein (the aglycone derivatives), whereas olive leaf extract is the preferred source for oleuropein-specific health applications.

### What is the bioavailability of oleuropein, and how does stomach acid affect its absorption?

Oleuropein has relatively low direct bioavailability due to its large molecular structure and susceptibility to degradation in the gastrointestinal tract; however, stomach acid and intestinal microbiota convert it to hydroxytyrosol and other smaller metabolites that are more readily absorbed. Enteric-coated or standardized olive leaf extracts may improve bioavailability by protecting oleuropein until it reaches the small intestine. Taking oleuropein with food, particularly fat-containing meals, may enhance absorption of its polyphenolic metabolites.

### What does current clinical research show about oleuropein's effectiveness for heart health and blood pressure?

Preclinical studies demonstrate that oleuropein reduces LDL oxidation and may lower blood pressure through angiotensin-converting enzyme (ACE) inhibition, with some human trials showing modest reductions in systolic and diastolic blood pressure. However, clinical evidence in humans remains limited, with most robust data coming from animal models and in vitro studies rather than large-scale randomized controlled trials. More human research is needed to establish clinically meaningful cardiovascular benefits and optimal dosing regimens.

### Who benefits most from oleuropein supplementation, and are there populations who should avoid it?

Individuals with oxidative stress-related conditions, cardiovascular concerns, or those seeking antioxidant support may benefit most from oleuropein supplementation, particularly if dietary olive leaf intake is limited. People taking ACE inhibitors or blood pressure medications should consult a healthcare provider before supplementing, as oleuropein may have additive hypotensive effects. Pregnant and breastfeeding women should avoid oleuropein supplements due to insufficient safety data in these populations.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*